Albemarle Corporation (ALB) : Mandatum Life Insurance Co Ltd added new position in Albemarle Corporation during the most recent quarter end. The investment management firm now holds 49,075 shares of Albemarle Corporation which is valued at $4,073,716 , the company said in a statement filed on Aug 12, 2016 with the SEC.Albemarle Corporation makes up approximately 0.53% of Mandatum Life Insurance Co Ltd’s portfolio.
Other Hedge Funds, Including , Us Financial Advisors sold out all of its stake in ALB during the most recent quarter. The investment firm sold 14 shares of ALB which is valued $1,162.Credit Suisse Ag boosted its stake in ALB in the latest quarter, The investment management firm added 146,493 additional shares and now holds a total of 323,152 shares of Albemarle Corporation which is valued at $26,824,848. Albemarle Corporation makes up approx 0.03% of Credit Suisse Ag’s portfolio.Texas Permanent School Fund reduced its stake in ALB by selling 33,644 shares or 37.47% in the most recent quarter. The Hedge Fund company now holds 56,134 shares of ALB which is valued at $4,659,683. Albemarle Corporation makes up approx 0.06% of Texas Permanent School Fund’s portfolio.Gamco Investors Et Al reduced its stake in ALB by selling 600 shares or 1.9% in the most recent quarter. The Hedge Fund company now holds 31,000 shares of ALB which is valued at $2,552,230. Albemarle Corporation makes up approx 0.02% of Gamco Investors Et Al’s portfolio.Baring Asset Management Ltd boosted its stake in ALB in the latest quarter, The investment management firm added 9,128 additional shares and now holds a total of 270,617 shares of Albemarle Corporation which is valued at $22,953,734. Albemarle Corporation makes up approx 1.81% of Baring Asset Management Ltd’s portfolio.
Albemarle Corporation opened for trading at $81.93 and hit $82.95 on the upside on Monday, eventually ending the session at $82.75, with a gain of 1.17% or 0.96 points. The heightened volatility saw the trading volume jump to 7,40,881 shares. Company has a market cap of $9,301 M.
On the company’s financial health, Albemarle Corporation reported $1.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.26 according to the earnings call on May 10, 2016. Analyst had a consensus of $0.86. The company had revenue of $865.40 million for the quarter, compared to analysts expectations of $814.81 million. The company’s revenue was down -2.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.17 EPS.
Investors should note that on Jul 11, 2016, Albemarle Corporation announced a cash dividend of $0.3050. The company’s management has announced Sep 13, 2016 as the ex-dividend date and fixed the record date on Sep 15, 2016. The payable date has been fixed on Oct 3, 2016.
Many Wall Street Analysts have commented on Albemarle Corporation. Company shares were Reiterated by Deutsche Bank on Jun 20, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $84 .
Albemarle Corporation (Albemarle) is a developer manufacturer and marketer of specialty chemicals across a range of end markets including the petroleum refining consumer electronics plastics/packaging construction automotive lubricants pharmaceuticals crop protection food-safety and custom chemistry services markets. The Company operates through two segments: Performance Chemicals and Catalyst Solutions. As of December 31 2014 the Performance Chemicals segment includes the Fire Safety Solutions Specialty Chemicals and Fine Chemistry Services product categories. As of December 31 2014 the Catalyst Solutions segment includes the Refinery Catalyst Solutions and Performance Catalyst Solutions product categories.